<DOC>
	<DOCNO>NCT00152919</DOCNO>
	<brief_summary>Swelling prostate occur brachytherapy . This swell cause urinary problem range difficulty void urinary retention . The purpose study investigate whether Mobicox start one week brachytherapy continue afterwards effective reduce risk need catheter Mobicox give afterwards .</brief_summary>
	<brief_title>Mobicox : Study Meloxicam Reduce Prostate Swelling Permanent Seed Prostate Brachytherapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Eligible receive prostate brachytherapy per Ontario Provincial Guidelines eligible study ( i.e . prostate specific antigen [ PSA ] &lt; 10 , Gleason score &lt; 7 , Stage &lt; = T2a ) Patients already take antiinflammatory drug Patients allergictype reaction , include asthma urticaria , aspirin nonsteroidal antiinflammatory agent ( see product information )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>